Vivos Therapeutics (VVOS)

• Market cap: $3.62M
• 1 day: -3.59%
• 5 days: 9.71%
• 1 month: -43.44%
• 3 months: -79.34%
• 6 months: -86.49%
• Year to date: -92.9%
• 1 year: -95.31%
• 5 years: -99.86%
• 10 years: -99.92%
• Sector: Healthcare
• Industry: Medical Devices

About: Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Employees: 268